OMNI Health Media Group proudly announces the appointment of Meg Monday as Director of Medical Education Advocacy. Meg brings more than 25 years of leadership experience in medical education, known for her ability to drive improved patient outcomes across complex disease states. Her work spans scientific communications, CME, and consumer-directed education, most recently serving as Executive Director of Content Development at Medscape.

Meg’s expertise aligns seamlessly with the OMNI Oncology mission: supporting community oncologists through strategically targeted informational, interactive programs and virtual tumor boards. She will play a key role in expanding OMNI’s reach and ensuring all offerings remain evidence-based, innovative, and focused on measurable improvements in patient care.

OMNI Oncology’s extensive program library delivers resources across the cancer spectrum. Through expert-led faculty, virtual tumor boards, timely newsletters, and real-world case discussions, OMNI Health Media Group is committed to equipping oncology teams with the latest advancements and actionable clinical insights.

“We are thrilled to welcome Meg Monday to our leadership team,” said Charles Weaver, MD, Founder and CEO. “Her dedication and strategic vision will accelerate our work in empowering clinicians and enhancing patient outcomes.”

For more information about OMNI Oncology’s programs and to stay up to date with new offerings, visit omnioncology.net or email chweaver@omnihealthmedia.com.

About OMNI Oncology
OmniOncology.net is a new digital platform designed exclusively for oncology healthcare professionals. The site offers evidence-based cancer care insights, clinical trial updates, and expert commentary to support informed decision-making in oncology practice.

Created by a team of oncologists, oncology pharmacists, oncology nurse specialists, and medical writers, OmniOncology delivers timely, peer-reviewed content across all major tumor types—including breast, lung, colorectal, prostate, hematologic malignancies, and rare cancers. Through expert analysis, curated research updates, and patient-focused content, OmniOncology strives to bridge the communication gap in cancer care—bringing critical knowledge to those who need it most.

Access to OmniOncology.net is intended for licensed healthcare providers and researchers. All content undergoes rigorous review to ensure accuracy, clinical relevance, and alignment with current oncology standards of care.